Metraipolis › archive › dc_cd3fa161af89

Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy — Europe PMC PMID:41471106

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41471106
DOI: 10.3390/pharmaceutics17121592
License (as archived): solo-consultazione
Archived: 2026-11-07T18:25:53.393Z
SHA-256 of the archived text: fc6b593442c756047c3f07d29f5a2a9b9a352f8621313aa566a3fabc969a68ec
Stable URL of this page: https://metraipolis.com/documento/dc_cd3fa161af89

How to cite

Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy — Europe PMC PMID:41471106 — Europe PMC (en), https://europepmc.org/article/MED/41471106 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd3fa161af89 (Metraipolis archive dc_cd3fa161af89, sha256 fc6b593442c756047c3f07d29f5a2a9b9a352f8621313aa566a3fabc969a68ec)

BibTeX

@misc{dccd3fa161af89,
  title = {Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy — Europe PMC PMID:41471106},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41471106},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd3fa161af89; sha256 fc6b593442c756047c3f07d29f5a2a9b9a352f8621313aa566a3fabc969a68ec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41471106. Agents can read the archived copy with the MCP tool read_document.